132 related articles for article (PubMed ID: 31944614)
1. Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - Potential impact on therapeutic decisions.
Franz F; Haschimi B; King LA; Auwärter V
Drug Test Anal; 2020 Mar; 12(3):391-396. PubMed ID: 31944614
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
[TBL] [Abstract][Full Text] [Related]
3. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R
N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
[TBL] [Abstract][Full Text] [Related]
5. Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MS.
Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
Biomed Chromatogr; 2020 Sep; 34(9):e4884. PubMed ID: 32415732
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
[TBL] [Abstract][Full Text] [Related]
7. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
Adamowicz P; Meissner E; Maślanka M
Clin Toxicol (Phila); 2019 Nov; 57(11):1103-1108. PubMed ID: 30806094
[No Abstract] [Full Text] [Related]
8. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.
Oliveira da Cruz JF; Ioannidou C; Pagano Zottola AC; Muguruza C; Gomez-Sotres P; Fernandez M; Callado LF; Marsicano G; Busquets-Garcia A
Addict Biol; 2021 May; 26(3):e12940. PubMed ID: 32744799
[TBL] [Abstract][Full Text] [Related]
10. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
[TBL] [Abstract][Full Text] [Related]
11. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
[TBL] [Abstract][Full Text] [Related]
12. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
[TBL] [Abstract][Full Text] [Related]
13. Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model.
Hsin-Hung Chen M; Dip A; Ahmed M; Tan ML; Walterscheid JP; Sun H; Teng BB; Mozayani A
J Cell Biochem; 2016 Apr; 117(4):1033-43. PubMed ID: 26517302
[TBL] [Abstract][Full Text] [Related]
14. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
[TBL] [Abstract][Full Text] [Related]
15. Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.
Finlay DB; Manning JJ; Ibsen MS; Macdonald CE; Patel M; Javitch JA; Banister SD; Glass M
ACS Chem Neurosci; 2019 Oct; 10(10):4350-4360. PubMed ID: 31513380
[TBL] [Abstract][Full Text] [Related]
16. Determine the pharmacokinetics (half-life, volume of distribution and clearance) of AMB-FUBINACA in rats plasma using GC-MS / MS.
Abdelgadir EH; Alshehri SD; Kumar S
J Pharmacol Toxicol Methods; 2024; 127():107513. PubMed ID: 38729531
[TBL] [Abstract][Full Text] [Related]
17. The phenomenon of para-Fluorophenylpiperazine (pFPP) in combination with the synthetic cannabinoid AMB-FUBINACA in seized plant material in New Zealand.
Johnson CS; Stansfield CR; Hassan VR; Kolbe E; Partington HK; Kappatos DC; Somerville RF
Forensic Sci Int; 2020 Feb; 307():110107. PubMed ID: 31951949
[TBL] [Abstract][Full Text] [Related]
18. Testing for AB-PINACA in human hair: Distribution in head hair versus pubic hair.
Arbouche N; Raul JS; Garnier D; Kintz P; Ameline A
Drug Test Anal; 2019 Apr; 11(4):610-616. PubMed ID: 30604522
[TBL] [Abstract][Full Text] [Related]
19. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
[TBL] [Abstract][Full Text] [Related]
20. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
